BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37753327)

  • 1. The effect of PACAP administration on LPS-induced cytokine expression in the Atlantic salmon SHK-1 cell line.
    Campbell JH; Dang X; Rodríguez-Ramos T; Carpio Y; Estrada MP; Dixon B
    Fish Shellfish Immunol Rep; 2023 Dec; 5():100116. PubMed ID: 37753327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PACAP Is Lethal to
    Semple SL; Rodríguez-Ramos T; Carpio Y; Lumsden JS; Estrada MP; Dixon B
    Front Immunol; 2019; 10():926. PubMed ID: 31105711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on IL-6, IL-8, and MCP-1 expression in human retinal pigment epithelial cell line.
    Zhang XY; Hayasaka S; Chi ZL; Cui HS; Hayasaka Y
    Curr Eye Res; 2005 Dec; 30(12):1105-11. PubMed ID: 16354624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP.
    Leceta J; Gomariz RP; Martinez C; Abad C; Ganea D; Delgado M
    Ann N Y Acad Sci; 2000; 921():92-102. PubMed ID: 11193883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression pattern of pituitary adenylate cyclase-activating polypeptide (PACAP) alternative splicing variants and its receptors in the immune system of rainbow trout (Oncorhynchus mykiss).
    Lugo JM; Tafalla C; Leceta J; Gomariz RP; Estrada MP
    Fish Shellfish Immunol; 2011 Feb; 30(2):734-8. PubMed ID: 21168508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for pituitary adenylate cyclase-activating peptide as a direct immunoregulator in teleost head kidney.
    Wang X; Wei H; Zhao T; Zhu X; Yang X; Chen D; Zhou H
    Fish Shellfish Immunol; 2013 Jan; 34(1):265-72. PubMed ID: 23153905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal alterations of pituitary adenylate cyclase activating polypeptide and its receptors in a rat model induced by recurrent chemical stimulations: Relevant to chronic migraine.
    Wu H; Dong Z; Liu Y; Zhang Q; Zhang M; Hu G; Yu S; Han X
    Mol Pain; 2023; 19():17448069231152129. PubMed ID: 36604785
    [No Abstract]   [Full Text] [Related]  

  • 11. First in vivo evidence of pituitary adenylate cyclase-activating polypeptide antiviral activity in teleost.
    Velázquez J; Pérez G; Semple SL; Rodríguez-Ramos T; Díaz-Rosales P; Ordás MDC; Lugo JM; Dixon B; Tafalla C; Estrada MP; Carpio Y
    Fish Shellfish Immunol; 2020 Aug; 103():58-65. PubMed ID: 32334130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
    Apostolakis EM; Riherd DN; O'Malley BW
    Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-{kappa}B in chronic pancreatitis.
    Michalski CW; Selvaggi F; Bartel M; Mitkus T; Gorbachevski A; Giese T; Sebastiano PD; Giese NA; Friess H
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G50-7. PubMed ID: 17962362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase activating polypeptide as a novel hypophysiotropic factor in fish.
    Wong AO; Li WS; Lee EK; Leung MY; Tse LY; Chow BK; Lin HR; Chang JP
    Biochem Cell Biol; 2000; 78(3):329-43. PubMed ID: 10949084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide inhibits cutaneous immune function.
    Kodali S; Friedman I; Ding W; Seiffert K; Wagner JA; Granstein RD
    Eur J Immunol; 2003 Nov; 33(11):3070-9. PubMed ID: 14579275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor.
    Soares MB; Titus RG; Shoemaker CB; David JR; Bozza M
    J Immunol; 1998 Feb; 160(4):1811-6. PubMed ID: 9469441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase activating polypeptide (PACAP) signalling exerts chondrogenesis promoting and protecting effects: implication of calcineurin as a downstream target.
    Juhász T; Matta C; Katona É; Somogyi C; Takács R; Gergely P; Csernoch L; Panyi G; Tóth G; Reglődi D; Tamás A; Zákány R
    PLoS One; 2014; 9(3):e91541. PubMed ID: 24643018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiological significance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the nervous system].
    Hashimoto H
    Yakugaku Zasshi; 2002 Dec; 122(12):1109-21. PubMed ID: 12510388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit LPS-stimulated MIP-1alpha production and mRNA expression.
    Pozo D; Guerrero JM; Calvo JR
    Cytokine; 2002 Apr; 18(1):35-42. PubMed ID: 12090758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.